- PLN580.03m
- PLN728.07m
- PLN370.57m
Brief: Selvita Unit's EUR 0.6 Mln Offer Chosen As Most Favourable In Tender
Brief: Selvita FY Net Profit Up At 30.3 Mln Zlotys
Brief: Selvita Holds Shares Representing 46.22% Of Voting Rights In Ardigen
Brief: Selvita Unit Receives EUR 2.6 Mln Order Under Framework Deal With European Pharmaceutical Company
Brief: Selvita Unit Receives EUR 2.3 Mln Order From European Pharmaceutical Company
Brief: Selvita Unit Gets EUR 1.2 Mln Order From U.S.-Based Biotech Company
Brief: Selvita Gets EUR 1.1 Mln Order From German Pharmaceutical Company
Brief: Selvita Says Shareholders Sell 5.45% Stake In Company At 78.70 Zlotys/Shr Under ABB
Brief: Selvita Two Shareholders Start ABB For Company's Shares
Brief: Selvita Q3 Net Result Turns To Profit Of 9.0 Mln Zlotys
Brief: Selvita Q2 Net Profit Up At 3.7 Mln Zlotys
Brief: Selvita Prelim Q2 Net Profit At 15.9 Mln Zlotys
Brief: Selvita Says Croatia-Based Unit Signs Research Services
Brief: TFI Allianz Polska Funds Hold 9.82% Stake In Selvita
Brief: Selvita AGM Resolves To Allocate FY Net Profit To Supplementary Capital
Brief: Selvita Says Unit Gets Permit For Investments Subject To 25% Tax Relief
Brief: Selvita Does Not Rule Out Share Issue For Breakthrough Transactions - CEO
Brief: Selvita Adopts Group Strategy For 2022-2025
Brief: Selvita FY Net Profit Down At 14.9 Mln Zlotys